Rtw Investments, LP Madrigal Pharmaceuticals, Inc. Transaction History
Rtw Investments, LP
- $6.51 Billion
- Q2 2025
A detailed history of Rtw Investments, LP transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 1,993,687 shares of MDGL stock, worth $849 Million. This represents 9.27% of its overall portfolio holdings.
Number of Shares
1,993,687
Previous 1,993,687
-0.0%
Holding current value
$849 Million
Previous $660 Million
8.63%
% of portfolio
9.27%
Previous 10.82%
Shares
6 transactions
Others Institutions Holding MDGL
# of Institutions
355Shares Held
23.2MCall Options Held
738KPut Options Held
473K-
Janus Henderson Group PLC London, X02.19MShares$933 Million0.34% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.09MShares$889 Million32.86% of portfolio
-
Baker Bros. Advisors LP New York, NY1.98MShares$841 Million6.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$799 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.88MShares$798 Million10.35% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $7.28B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...